# SPINRAZA
> **NDA209531** · New Drug Application · Sponsor: BIOGEN IDEC · Approved 2016-12-23
## Drug
- **FDA Application Number:** NDA209531
- **Application type:** New Drug Application
- **Brand name:** SPINRAZA
- **Generic name:** NUSINERSEN
- **Active ingredients:** NUSINERSEN SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRATHECAL
- **Marketing status:** Prescription
- **Sponsor:** BIOGEN IDEC
- **Manufacturer:** Biogen Inc.
- **First approval:** 2016-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209531)
---
*AI Analytics · CC0 1.0*